Product Details
| Product Name:
CID755673 |
CAS No.:
521937-07-5 |
| Purity:
99.84% |
Supply Ability:
10g |
| Release date:
2025/06/22 |
Product Introduction
Bioactivity
| Name | CID755673 |
| Description | CID755673 is an effective and specific cell-active inhibitor for PKD (IC50: 182 nM); exhibits selective PKD1 inhibition when compared with PLK1, AKT, CAMKIIα, CAK, and PKC isoforms. |
| Cell Research | Cell proliferation was determined by counting the number of viable cells upon trypan blue staining. Cell proliferation is measured by CellTiter-Glo Luminescent Cell Viability Assay according to the manufacturer's instructions.(Only for Reference) |
| Kinase Assay | In Vitro Radiometric PKD Kinase Assay: The radiometric kinase assay is carried out by coincubating 0.5 μCi of [γ-32P]ATP, 20 μM ATP, 50 ng of purified recombinant human PKD (PKD1, PKD2, and PKD3) or CAMKIIα proteins, and 2.5 μg of Syntide-2 in 50 μl of kinase buffer that contains 50 mM Tris-HCl, pH 7.5, 4 mM MgCl2, 10 mM β-mercaptoethanol. The reaction is carried out under conditions that the initial rate is within the linear kinetic range. The filter papers are then washed three times in 0.5% phosphoric acid, air-dried, and counted using a Beckman LS6500 multipurpose scintillation counter. |
| In vitro | In an acute pancreatitis model in rats, CID755673 significantly ameliorates the severity of necrosis and pancreatitis through its inhibitory action on PKD/PKD1. |
| In vivo | In HeLa cells, CID755673 significantly blocks the PMA-induced nuclear export of HDAC5 and also inhibits protein transport mediated by PKD. Furthermore, CID755673 directly inhibits the activity of PKD1 in LNCaP prostate cancer cells. This compound effectively prevents the migration and invasion of prostate cancer cells, as well as inhibiting tumor cell proliferation, and altering cell cycle distribution. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice./Shipping at ambient temperature. |
| Solubility Information | DMSO : 65 mg/mL (299.24 mM), Sonication is recommended.
|
| Keywords | threoninkinase | threonin kinase | Serinekinase | Serine kinase | Protein kinase D | PKD3 | PKD2 | PKD1 | PKD | Inhibitor | inhibit | CID-755673 | CID755673 | CID 755673 |
| Inhibitors Related | Fasudil | Piceatannol | Chymotrypsin | Fasudil hydrochloride | Camostat mesylate | SRPIN340 | HA-1004 | 6-(Dimethylamino)purine | FOY 251 | BMT-124110 Formate | Benzamidine hydrochloride | Cetraxate hydrochloride |
| Related Compound Libraries | Highly Selective Inhibitor Library | Target-Focused Phenotypic Screening Library | Bioactive Compound Library | Kinase Inhibitor Library | Inhibitor Library | NO PAINS Compound Library | Metabolism Compound Library | Bioactive Compounds Library Max | Cell Cycle Compound Library | Anti-Cancer Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:86583-19-9
$128.00 / 1mg
-
CAS:15622-65-8
$30.00 / 10mg
-
CAS:2411972-78-4
$195.00 / 1mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |
United States